title: Gabapentin-induced encephalopathy.
authors.affiliation: Department of Clinical Neurophysiology, CHU, Dijon 21000, France. Electronic address: katell.beauvais@chu-dijon.fr.
authors.forename: K
authors.initials: K
authors.lastname: Beauvais
authors.affiliation: Burgundy Regional Pharmacovigilance Centre, CHU, Dijon 21000, France.
authors.forename: A
authors.initials: A
authors.lastname: Disson-Dautriche
authors.affiliation: Department of Clinical Neurophysiology, CHU, Dijon 21000, France.
authors.forename: A
authors.initials: A
authors.lastname: Jacquin
authors.affiliation: Department of Clinical Neurophysiology, CHU, Dijon 21000, France.
authors.forename: C
authors.initials: C
authors.lastname: Antoniol
authors.affiliation: Department of Clinical Neurophysiology, CHU, Dijon 21000, France.
authors.forename: M Lemesle
authors.initials: ML
authors.lastname: Martin
mesh_terms: D000369:Aged, 80 and over; D000588:Amines / Q000009:adverse effects*; D000927:Anticonvulsants / Q000009:adverse effects*; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects*; D004569:Electroencephalography / Q000187:drug effects; D005260:Female; D000077206:Gabapentin; D006801:Humans; D020258:Neurotoxicity Syndromes / Q000175:diagnosis* / Q000503:physiopathology; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects*
chemical_list: D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin